CHEOY:OTCMKTS
Cochlear Ord ADR
$44.60
arrow_downward
-0.35%(-0.15) 1D
Oct 15, 1:13:45 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHEOY...
Open
$44.61
High
$44.82
Low
$44.60
Mkt. cap
8.42B
Avg. vol.
18.50K
Volume
13.34K
52-wk high
$98.49
52-wk low
$31.82
Beta
0.68
Shares outstanding
130.80M
No. of employees
5K
Open
$44.61
High
$44.82
Low
$44.60
Mkt. cap
8.42B
Avg. vol.
18.50K
Volume
13.34K
52-wk high
$98.49
52-wk low
$31.82
Beta
0.68
Shares outstanding
130.80M
No. of employees
5K
News stories
From web sources and news partners
Stocks Down Under
·
19 hours ago
Cochlear (ASX:COH) Share Price, Forecast & Analysis
Financial Times
·
1 day ago
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ord ADR
CEODig Howitt
Employees5.4K
Founded1981
HeadquartersSydney, New South Wales, Australia
SectorMedical device
Websitecochlear.com